Model
Edge
4D Molecular Therapeutics
0001834021
Filing Type
4
Filing Date
7/11/2024
Updated
7/12/24, 3:46 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership